Bayer | BAYN - Stock


Bayer reported EUR12.01B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Air Liquide EUR 2.13B 53.7M Dec/2025
Akzo Nobel EUR 1.61B 80M Mar/2026
Alcon AG USD 2.44B 47M Mar/2026
Amarin USD 164.07M 19.51M Jun/2026
Arkema EUR 1.3B 157M Mar/2026
AstraZeneca USD 6.93B 362M Jun/2026
BASF EUR 12.91B 850M Mar/2026
Bayer EUR 12.01B 321M Mar/2026
Beiersdorf EUR 1.61B 63M Dec/2025
Corteva USD 4.44B 759M Jun/2026
Covestro EUR 2.5B 108M Dec/2025
Essilor EUR 3.54B 187M Dec/2025
Fresenius EUR 2.73B 119M Mar/2026
Fresenius Medical Care EUR 2.3B 162.24M Mar/2026
Genmab DKK 21M 8M Mar/2026
Givaudan CHF 1.45B 177M Jun/2024
GlaxoSmithKline GBP 6.16B 233M Mar/2026
GRIFOLS EUR 3.49B 34M Jun/2026
Henkel EUR 2.36B 196M Dec/2025
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
Johnson Matthey GBP 1.55B 455M Jun/2022
Linde USD 2.08B 24M Mar/2026
Lonza CHF 1.68B 163M Dec/2025
Merck EUR 4.78B 220M Mar/2026
Novartis USD 6.22B 66M Jun/2026
Nutrien USD 6.16B 2.52B Jun/2026
Philips EUR 3.22B 106M Jun/2026
PPG Industries USD 2.23B 64M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026
Solvay EUR 579M 13M Jun/2026
UCB EUR 1.31B 173M Dec/2024
Umicore EUR 2.55B 254.35M Dec/2025
Vinci EUR 1.7B 108M Dec/2025